Supplement Formulators
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Supplement Formulators sits in the top decile of US sponsors by registered trial count (#987 of 15,742 sponsors by registered trial count).
Supplement Formulators: 14 sponsored US clinical trials, 1 recruiting.
Supplement Formulators sponsors 14 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 9 completed. The most-studied condition in this pipeline is Body Weight Changes, with 1 trials.
Top-decile sponsor footprint
Supplement Formulators ranks in the top decile of sponsors by registered trial count (#987 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
9 of 12 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (75.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
14 total, page 1 of 1
A Study to Evaluate the Effects of a Butyrate-Polyphenol Formulation on Gut Health and Associated Symptoms
NCT07371975
Effects of a Theanine for Stress Relief Formulation in Individuals Who Report Occasional Moderate High Levels of Stress.
NCT05854017
Effectiveness of a Butyrate Formulation and Butyrate + Polyphenol Formulation on Gut Health, Permeability and Associated Symptoms
NCT06419231
Evaluate the Effects of a Theanine Formulation on Stress, Burnout, Mood, and Sleep in Individuals Who Report Occasional Moderate or High Levels of Stress
NCT05450952
Evaluate the Effectiveness and Safety of the Alpinia Galanga Formulation, Theacrine Formulation, and Caffeine Formulation on Fatigue, Mental Acuity, and Cognitive Health
NCT05170113
Evaluate the Effects of a Marine Lipid Oil Concentrate Formulation on Inflammation/Discomfort
NCT04819646
To Assess the Efficacy and Safety of the Cardio Formulation in Reducing Oxidized LDL
NCT04317287
A Study to Evaluate the Effects of a Marine Lipid Oil Concentrate Formulation on Inflammation
NCT04269876
Study to Evaluate the Effects of a Weight Management Program on Body Weight
NCT04107155
Open-label Study to Assess Increasing Levels of NAD+(Nicotinamide Adenine Dinucleotide)
NCT03707652
Evaluate the Effects of Repeated Periods of Modified Fasting to Support Healthy Natural Weight Management and Prevention of Weight Gain
NCT03372109
A Study to Evaluate the Effects of a Turmeric and Black Cumin Seed Formulation on Cholesterol Levels
NCT03175757
A Study to Evaluate the Effects of a Prostate Health Formulation
NCT02886832
Comparing Blood Sugar Levels and Endothelial Function of PEAK ATP® With GlycoCarn®, PEAK ATP® and GlycoCarn® Supplements
NCT01855373
Therapeutic Areas
What is open in the Supplement Formulators pipeline
1 recruiting of 14 indexed (7% open); 9 completed (64%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Body Weight Changes (1 trial), 3 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Supplement Formulators: open-pipeline peers nationwide
Peers matched on 14 registered trials and 7% open enrollment, not the therapeutic-area sidebar.
Supplement Formulators sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 14 trials (± recruiting share)
- 3-C Institute for Social Development · 14 trials · 0% recruiting
- Abbott Medical Optics · 14 trials · 0% recruiting
- Abbott RDx Cardiometabolic · 14 trials · 0% recruiting
- Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA · 14 trials · 0% recruiting
Sponsors near 7% open enrollment (± trial volume)
- Carol Fabian, MD · 7% recruiting · 14 trials
- Celldex Therapeutics · 7% recruiting · 42 trials
- Kaiser Permanente · 7% recruiting · 294 trials
- Mannkind Corporation · 7% recruiting · 42 trials
Related
What to do with this Supplement Formulators page
14 registered trials is a research-attention snapshot, not an endorsement of Supplement Formulators or any single study.
- 1 of Supplement Formulators's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Body Weight Changes is the condition Supplement Formulators studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Body Weight Changes trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Supplement Formulators pipeline card: 14 registered trials from official public datasets.Report a data error.